Organization

AMERIPATH FLORIDA LLC

According to 2025 Medicare claims, AMERIPATH FLORIDA LLC (NPI: 1619940517) practices clinical laboratory (billing independently) in the Cape Coral-Fort Myers, FL market, with the plurality of this provider's patient population coming from Lee, FL. This provider's primary affiliated billing organization is AMERIPATH FLORIDA LLC (NPI: 1619940517; TIN: 650641688) and primary practice location at 33617-2026. LLC is affiliated with the Genuine Health Direct, LLC (ACO ID: D0008), Rancho Health Management, LLC (ACO ID: D0015), CareMount Value Partners IPA (ACO ID: D0019), Advanced Illness Partners, LLC (ACO ID: D0097), Esse Health ACO, LLC (ACO ID: D0140), Humana Direct Contracting Entity, Inc. (ACO ID: D0203), APA ACO Inc. (ACO ID: D0215), Pearl Primary Care Network, LLC (ACO ID: D0242), Pearl Network, LLC (ACO ID: D0243), and CINQCARE ACO REACH LLC (ACO ID: D0284), participating under the REACH model.

The organization's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 6,557 traditional Medicare patients, billed 24,226 HCPCS/CPT codes, and received $937,109 in Medicare payments. The top billing code was 88342 (Special stained specimen slides to examine tissue, initial procedure). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $1,897,098 to $937,109. Concurrently, this provider has fewer than 5 years of reported Part D prescription costs data, so a reliable trend cannot be assigned. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$949K$1.9M2015 Medicare payment: $1,897,098 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,771,583 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,508,222 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,464,171 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,423,149 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $896,770 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $882,449 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $810,606 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $889,559 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $937,109 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201513,17054,612$1,897,098
201612,44049,415$1,771,583
201711,85641,631$1,508,222
201813,64539,120$1,464,171
201911,86537,830$1,423,149
20207,06924,737$896,770
20216,54423,278$882,449
20226,28222,116$810,606
20236,45924,431$889,559
20246,55724,226$937,109

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

No connected Part D records

No connected Part D records

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
88342Special stained specimen slides to examine tissue, initial procedure1,3002,084$47
88341Special stained specimen slides to examine tissue, each additional procedure6533,189$44
88112Cell examination of specimen, selective cellular enhancement technique7221,173$31
88305Pathology examination of tissue using a microscope, intermediate complexity3,6668,862$31
88304Pathology examination of tissue using a microscope, moderately low complexity6871,169$18

Top 5 Part D drugs in 2024

By total drug costs.

No connected Part D drug-level records for 2024.

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for AMERIPATH FLORIDA LLC?

Tedicare shows public-source Medicare data for AMERIPATH FLORIDA LLC (NPI 1619940517), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does AMERIPATH FLORIDA LLC have ACO affiliation data?

AMERIPATH FLORIDA LLC is shown with ACO affiliation data for Genuine Health Direct, LLC (REACH, ACO ID D0008), Rancho Health Management, LLC (REACH, ACO ID D0015), CareMount Value Partners IPA (REACH, ACO ID D0019), Advanced Illness Partners, LLC (REACH, ACO ID D0097), Esse Health ACO, LLC (REACH, ACO ID D0140), Humana Direct Contracting Entity, Inc. (REACH, ACO ID D0203), APA ACO Inc. (REACH, ACO ID D0215), Pearl Primary Care Network, LLC (REACH, ACO ID D0242), Pearl Network, LLC (REACH, ACO ID D0243), and CINQCARE ACO REACH LLC (REACH, ACO ID D0284).

What billing organization is linked to AMERIPATH FLORIDA LLC?

AMERIPATH FLORIDA LLC is linked to AMERIPATH FLORIDA LLC (billing NPI 1619940517) in the available physician profile data.

Does AMERIPATH FLORIDA LLC have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.